AERPIO PHARMACEUTICALS INC's ticker is ARPO and the CUSIP is 00810B105. A total of 22 filers reported holding AERPIO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $322,000 | +126.8% | 257,554 | 0.0% | 0.01% | +100.0% |
| Q1 2020 | $142,000 | -11.8% | 257,554 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $161,000 | -8.0% | 257,554 | 0.0% | 0.01% | -25.0% |
| Q3 2019 | $175,000 | -74.0% | 257,554 | -65.2% | 0.01% | -70.4% |
| Q2 2019 | $673,000 | +0.9% | 740,000 | 0.0% | 0.03% | 0.0% |
| Q1 2019 | $667,000 | -48.7% | 740,000 | -3.3% | 0.03% | -51.8% |
| Q4 2018 | $1,301,000 | -45.0% | 765,000 | 0.0% | 0.06% | -34.9% |
| Q3 2018 | $2,364,000 | -25.5% | 765,000 | 0.0% | 0.09% | -28.3% |
| Q2 2018 | $3,175,000 | – | 765,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 5,621,835 | $9,501,000 | 5.16% |
| ABG Innovation Capital Partners III GP Ltd | 400,000 | $676,000 | 2.26% |
| Ikarian Capital, LLC | 1,676,093 | $2,832,000 | 0.23% |
| Avoro Capital Advisors LLC | 4,500,000 | $7,605,000 | 0.13% |
| Parkman Healthcare Partners LLC | 353,957 | $598,000 | 0.13% |
| Orbimed Advisors | 5,193,946 | $8,778,000 | 0.09% |
| RA Capital Management | 2,693,309 | $4,552,000 | 0.07% |
| Atom Investors LP | 79,996 | $135,000 | 0.02% |
| NEVILLE RODIE & SHAW INC | 100,000 | $169,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 208,674 | $353,000 | 0.01% |